POLR3G and cancer: The human forms of RPC7α and RPC7β share 46% amino acid identity and recent evidence suggests differences in RPC7 subunit incorporation may shape Pol III activity with implications for cellular growth, proliferation, and cancer progression [7,10,11,12,13].